Yayınlar & Eserler

Yayın Ağı
Makaleler 21
Tümü (21)
SCI-E, SSCI, AHCI (17)
SCI-E, SSCI, AHCI, ESCI (21)
ESCI (4)
Scopus (20)
TRDizin (4)

1. Biphasic squamoid papillary renal cell carcinoma: clinicopathological features of nine cases

Akin A. E., Guner G., Kosemehmetoglu K.
VIRCHOWS ARCHIV , 2024 (SCI-Expanded, Scopus) identifier

2. Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?

GÜNER G., AKTAŞ B. Y., Başal F. B., DEMİRKAZIK A., Gürsoy P., Demirci U., et al.
Journal of Cancer Research and Clinical Oncology , cilt.149, sa.14, ss.13271-13277, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

3. Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia

AKTAŞ B. Y., ATA E. B., ÇEŞMECİ E., ÇAKIR İ. Y., Coşkunpınar M., TAHILLIOĞLU Y., et al.
Current Oncology , cilt.30, sa.11, ss.9689-9700, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

4. Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience

DEMİR M., Guven D., AKTAŞ B. Y., GÜNER G., AKTEPE O. H., TABAN H., et al.
SOUTH ASIAN JOURNAL OF CANCER , cilt.11, ss.287-292, 2022 (ESCI, Scopus) Creative Commons License identifier identifier identifier

5. Detection and Local Staging of Prostate Cancer by [68Ga]Ga-PSMA-PET/CT, Comparison with mpMRI and Histopathology

Isik Z., Guner G., Caglar M., Karcaaltincaba M., Akdogan B., Akinci D., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus) identifier

6. Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy

YILDIRIM H. Ç., GÜVEN D. C., AKTEPE O. H., TABAN H., YILMAZ F., YAŞAR S., et al.
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , cilt.6, sa.1, ss.59-63, 2022 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

7. Correlation Between THSD7A Expression and Tumor Characteristics of Azoxymethane-Induced Colon Cancer Model in Rats

AKTEPE O. H., ŞAHİN T. K., GÜNER G., GÜVEN D. C., YETER H. H., KURTULAN O., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.32, sa.12, ss.1049-1056, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier identifier

8. The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors

Guven D. C., Aktepe O. H., Aksun M. S., Sahin T. K., Kavgaci G., Ucgul E., et al.
ANNALS OF ONCOLOGY , cilt.32, 2021 (SCI-Expanded, Scopus) identifier

9. Sarcopenia and anthracycline cardiotoxicity in patients with cancer

BAŞ O., ERDEMİR A. G., ONUR M. R., ÖZER N., ŞENER Y. Z., AKSU S., et al.
BMJ SUPPORTIVE & PALLIATIVE CARE , 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

10. Lower prognostic nutritional index is associated with poorer survival in patients receiving immune-checkpoint inhibitors

GÜVEN D. C., AKTEPE O. H., TABAN H., AKTAŞ B. Y., GÜNER G., YILDIRIM H. H., et al.
BIOMARKERS IN MEDICINE , cilt.15, sa.13, ss.1123-1130, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement

Bilgin B., Sendur M. A. N., Yucel S., Hizal M., GÜNER G., AKYÜREK N., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.147, sa.9, ss.2637-2643, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

12. Solitary fibrous tumour (SFT) of kidney and renal hilus: 15 cases with special emphasis onSTAT6 and PAX8 expression

Guner G., Michal M., Yazgan A., Kandemir N. O., Ocal B. G., Lopez J., et al.
VIRCHOWS ARCHIV , cilt.479, sa.SUPPL 1, 2021 (SCI-Expanded, Scopus) identifier

13. Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma

AKTEPE O. H., GÜNER G., GÜVEN D. C., TABAN H., YILDIRIM H. Ç., ŞAHİN T. K., et al.
TURKISH JOURNAL OF UROLOGY , cilt.47, sa.2, ss.113-119, 2021 (ESCI, Scopus, TRDizin) identifier identifier identifier identifier

14. Prognostic and predictive value of tumor-infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer

Efil S. C., Guner G., Guven D. C., Celikten B., Celebiyev E., Taban H., et al.
ANNALS OF ONCOLOGY , cilt.32, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier

15. What to expect from NCCN BRCA testing criteria: A retrospective cohort analysis

Aktas B. Y., Degirmenciler R. F., Durmaz C. D., Taban H., Guven D. C., Guner G., et al.
ANNALS OF ONCOLOGY , cilt.32, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier

16. Defining the Optimal Regimen for Stage III Colon Cancer: Concerns with Study Design

GÜVEN D. C., GÜNER G., AKTAŞ B. Y., AKTEPE O. H., TABAN H., ARIK Z.
CLINICAL COLORECTAL CANCER , cilt.19, sa.3, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

17. Frailty and its Correlates in Older Adults: A Challenging and Preventable Geriatric Syndrome

DOĞAN VARAN H., KILIÇ M., KIZILARSLANOĞLU M. C., TUNA DOĞRUL R., Arik G., Kara O., et al.
ERCIYES MEDICAL JOURNAL , cilt.42, sa.2, ss.150-156, 2020 (ESCI, TRDizin) Creative Commons License identifier

18. Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer

GÜVEN D. C., KILIÇKAP S., GÜNER G., TABAN H., DİZDAR Ö.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.1, ss.256-258, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

19. Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy

AKTAŞ B. Y., Guner G., Guven D. C., Arslan C., DİZDAR Ö.
EXPERT REVIEW OF ANTICANCER THERAPY , cilt.19, sa.7, ss.589-601, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

20. Glucocorticoids in breast cancer treatment: real benefit or selection bias?

Guner G., DİZDAR Ö.
BREAST CANCER RESEARCH AND TREATMENT , cilt.172, sa.1, ss.243, 2018 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

21. Higher Serum Endocan Level Is Associated with Alzheimer Disease

DOĞAN VARAN H., GÜNER G., KIZILARSLANOĞLU M. C., SÜMER F., TUNA DOĞRUL R., Sagir A., et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS , cilt.44, ss.303-310, 2017 (SCI-Expanded, Scopus) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 8

1. Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic

Guven D. C., Ceylan F., Cakir I. Y., Cesmeci E., Sayinalp B., Yesilyurt B., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31, (Özet Bildiri) Creative Commons License identifier

2. Relationship between sarcopenia and anthracycline related cardiotoxicity in patients with cancer

Bas O., Erdemir A., Onur R., Guner G., Guven D. C., Aksu S., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

3. Changes in the outpatient and inpatient clinic admissions during COVID-19 pandemic: Anticipating and mitigating risks for cancer patients

Guven D. C., Aktas B. Y., Aksun M. S., Ucgul E., Sahin T. K., Yildirim H. C., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

4. Embedded outpatient palliative care service within the oncology clinic: Preliminary experience in Hacettepe Oncology Hospital

Guven D. C., AKTEPE O. H., Berk Z., Guner G., Taban H., AKTAŞ B. Y., et al.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, (Özet Bildiri) identifier

5. Clinicopathologic features of BRCA mutated breast cancer patients: Hacettepe experience

AKSOY S., DEĞİRMENCİLER R. F., AKTAŞ B. Y., Guven D. C., AKTEPE O. H., Guner G., et al.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

6. Clinical features and prognosis of patients with liposarcoma: Single-center experience.

Demir M., Guven D. C., Aktas B. Y., Guner G., Aktepe O. H., Taban H., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37, (Özet Bildiri) identifier

7. Metastatic Choroidal Melanoma: Single Center Experience

AKTAŞ B. Y., GÜNER G., DEMİR M., GÜVEN D. C., AKTEPE O. H., BÖLEK E. Ç., et al.
2. Ulusal İmmunoterapi ve Onkoloji Kongresi, Antalya, Türkiye, 31 Ekim - 04 Kasım 2018, ss.1-48, (Tam Metin Bildiri)

8. Possible Effect of Physical Frailty on Mood Changes in Older Adults

Dogrul R. T., Kizilarslanoglu M., Varan H. D., Kilic M., Sumer F., Kara O., et al.
Annual Scientific Meeting of the American-Geriatrics-Society, California, Amerika Birleşik Devletleri, 19 - 21 Mayıs 2016, cilt.64, (Özet Bildiri) identifier
Metrikler

Yayın

29

Yayın (WoS)

28

Yayın (Scopus)

20

Atıf (WoS)

19

H-İndeks (WoS)

2

Atıf (Scopus)

12

H-İndeks (Scopus)

2

Proje

1

Açık Erişim

9
BM Sürdürülebilir Kalkınma Amaçları